SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CYTR: CytRx Corporation
CYTR 0.09200.0%Oct 5 5:00 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
From: mlkr6/26/2010 11:08:21 AM
   of 51
 
CYTR: A sample of recent news: Very active press release record!
CytRx Set to Join the Russell 3000 Index
06/07/2010 8:30AM CytRx Announces Issuance of Key U.S. Patent Covering Bafetinib
06/04/2010 8:30AM CytRx to Present at the Jefferies 2010 Global Life Sciences Conference
05/28/2010 1:00PM CytRx Initiates Phase 2 Clinical Trial with Bafetinib in B-cell Chronic Lymphocytic Leukemia
05/27/2010 8:30AM Research Trial Evaluating CytRx’s Bafetinib in Brain Tumor Model to be Presented at the American Society of Clinical Oncolo...
05/18/2010 12:47PM Proxy Statement (definitive) (DEF 14A)
05/11/2010 8:30AM CytRx to Present at the Rodman & Renshaw Annual Global Healthcare Conference in London
05/06/2010 8:39AM Current report filing (8-K)
05/06/2010 8:37AM Quarterly Report (10-Q)
05/06/2010 8:30AM CytRx Reports 2010 First Quarter Financial Results
05/03/2010 8:30AM CytRx’s INNO-206 Rapidly Shrinks Human Tumors in an Animal Model of Multiple Myeloma
04/20/2010 8:30AM CytRx’s Bafetinib Receives Positive Opinion from the Committee for Orphan Medicinal Products in the European Union for Trea...
04/07/2010 8:30AM CytRx to Initiate a Phase 2 Clinical Trial with Bafetinib in Advanced Prostate Cancer
03/25/2010 3:29PM Current report filing (8-K)
03/25/2010 8:30AM CytRx Chief Executive Officer & Chief Medical Officer Discuss Corporate Strategy & Development Pipeline in Fireside Chat with...
03/23/2010 1:15PM CytRx to Receive $3.8 Million from Sale of RXi Pharmaceuticals Common Stock
03/15/2010 8:32AM Annual Report (10-K)
03/15/2010 8:31AM Current report filing (8-K)
03/15/2010 8:30AM CytRx Reports 2009 Fourth Quarter Financial Results
03/08/2010 8:30AM CytRx to Present at the Roth Capital Partners OC Growth Stock Conference
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News